plutoniumimplosion Member Level Tuesday, 05/16/17

New Post Public Reply Private Reply Replies (1) Message Board
sal32647
1,391
plutoniumimplosion Member Level Tuesday, 05/16/17 09:51:10 AM
Re: zoran post# 43969
Post #
43971
of 43971 Go

From other board...


DECN is spreading all over the face of J&J....unfortunately for J&J their is no cure.

An excellent choice of words. So, lets visit a few facts and a sprinkling of speculation.

The DECN victory in court over J&J last March was totally unexpected. J&J's pleadings were compelling. New handles sprung up here to tout these pleadings. The problem was, the judge didn't buy the pleadings, even as he admonished them for not following court rules trying to turn a Motion for Dismissal into a Summary Judgement motion in disguise. That IMO is a big thing.

But there are also little things. For example, J&J dismissed Unistrip from two lawsuits, one filed in Pennsylvania Federal Court, another filed in North Carolina Federal Court. I asked myself why would J&J dismiss Unistrip when they were going to win (and J&J was winning in a rout)? Answer! J&J could not beat (= destroy) DECN by themselves. So, the next best thing to confronting DECN was to enlist a little help. Unistrip is pretty much finished in the U.S. markets, but they are not finished in Europe where reputations are slower to take shape -- nobody has died yet in Europe from using a Unistrip or Prodigy test strip, although very few have bought them. So an unshackled Unistrip would provide that small amount of help to J&J, at least until DECN adds Unistrip to the Las Vegas court case.

And that makes DECN more than just a pimple.

All IMO.
1

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Astrana Health Strengthens Market Position with Recent Acquisitions

Updated Category News Views 604

Astrana Health Completes Strategic Acquisitions Astrana Health, Inc. (NASDAQ:ASTH), a prominent management consulting services provider, has successfully concluded its acquisition of several healthcare entities. This strategic move represents a significant milestone in the expansion of its operations within the healthcare management sector. The company recently finalized...

Continue Reading
Celebrating 65 Years: A Journey Through Innovations in Flexography

Updated Category News Views 88

Anderson & Vreeland: A Milestone Celebration Anderson & Vreeland Inc. (NASDAQ: A&V), known affectionately as A&V, proudly celebrates its 65th anniversary, reflecting on over six decades of pioneering service in the flexographic printing industry. Since launching operations in January 1961, the company has continually adapted and evolved to serve the needs of its customers...

Continue Reading
Hyatt on the Hook: $15.5M Verdict Spurs Industry Wake-Up Call

Updated Category News Views 21

Hyatt Takes a Hit: $15.5 Million Verdict The courtroom doors swung open, and out came a staggering $15.5 million verdict against Hyatt, plastering the corporation's name across every investor's radar today. Not some chump change, I tell ya. This hefty figure stems from a case involving the tragic death of Cindy Gonzalez, a diabetic hotel guest left high and dry by...

Continue Reading
Rocket Lab USA Inc Faces Legal Challenges Amid Performance Issues

Updated Category News Views 518

Legal Concerns Surrounding Rocket Lab USA Inc. Recent events have raised significant legal concerns for Rocket Lab USA, Inc. (NASDAQ: RKLB). The national shareholder rights law firm Bragar Eagel & Squire, P.C. is actively investigating potential claims against the company on behalf of its long-term stockholders. These inquiries stem from a class action lawsuit filed...

Continue Reading
Klarna Group PLC: Short Interest and Market Sentiment Insights

Updated Category News Views 277

Analyzing Market Sentiment Around Klarna Group PLC A storm’s brewing if you’re watching Klarna Group PLC's short interest data. Just to give you a pulse on the situation, short interest has spiked by 21.74% since the last report. We’re talking about a whopping 16.95 million shares sold short, which translates to 6.16% of available shares. Now, as the dust settles,...

Continue Reading